Revolutionizing Drug Screening: Medera’s Groundbreaking Study Utilizing Machine Learning and Human Mini-Heart Technology
Revolutionizing Drug Screening with AI and Human Mini-Hearts The Challenge of Traditional Methods Traditional methods for evaluating therapeutic efficacy and cardiotoxicity often lead to high failure rates during clinical trials, resulting in significant development costs. Human-specific diseases cannot be accurately modeled by animals, leading to limited medical options or advancements. The Solution: AI and Human…